139
Participants
Start Date
December 16, 2022
Primary Completion Date
January 21, 2025
Study Completion Date
April 11, 2025
Ozanimod
Specified dose on specified days
Local Institution - 0176, New York
Local Institution - 0170, Utica
Local Institution - 0197, Lynchburg
Local Institution - 0050, Homestead
Local Institution - 0037, Palm Harbor
Local Institution - 0183, Louisville
University of Wisconsin Hospital and Clinics, Madison
Local Institution - 0198, Arlington Heights
Local Institution - 0098, Gurnee
Local Institution - 0051, Chicago
Local Institution - 0138, Dallas
Ace Clinical Research Group: Digestive Health Associates, Houston
Houston Methodist Hospital, Houston
Local Institution - 0052, Houston
Local Institution - 0038, Bellaire
Novel Research LLC, Bellaire
Local Institution - 0129, Katy
Local Institution - 0091, Webster
Local Institution - 0185, San Jose
Local Institution - 0048, Dothan
Local Institution - 0206, Chandler
Local Institution - 0216, Gilbert
Local Institution - 0125, Sun City
Local Institution - 0195, Tucson
Local Institution - 0045, North Little Rock
Local Institution - 0165, Apple Valley
Local Institution - 0162, Camarillo
Local Institution - 0014, Lancaster
OM Research LLC - Lancaster - ClinEdge - PPDS, Lancaster
Local Institution - 0209, Los Angeles
Local Institution - 0002, San Diego
Local Institution - 0208, San Diego
Local Institution - 0178, Littleton
Gastro Florida, Clearwater
Local Institution - 0018, Clearwater
Local Institution - 0026, Lighthouse PT
Local Institution - 0167, Miami
Local Institution - 0049, Miami Lakes
Wellness Clinical Research-Miami Florida, Miami Lakes
Gastroenterology Group of Naples, Naples
Local Institution - 0003, Naples
Local Institution - 0058, Orange Park
Local Institution - 0205, Orlando
Local Institution - 0179, Wellington
Local Institution - 0027, Roswell
Local Institution - 0192, Kansas City
Local Institution - 0181, Topeka
Local Institution - 0200, Baton Rouge
Local Institution - 0171, Chevy Chase
Local Institution - 0191, Glen Burnie
Local Institution - 0199, Boston
Local Institution - 0196, Worcester
Local Institution - 0174, Plymouth
Local Institution - 0184, Ocean Springs
Local Institution - 0024, Chesterfield
Local Institution - 0213, Weldon Spring
Local Institution - 0180, Englewood
Local Institution - 0084, Brooklyn
Local Institution - 0187, New York
Local Institution - 0059, New York
NYU Langone Health -Inflammatory Bowel Disease Center, New York
Carolina Digestive Diseases, Greenville
Local Institution - 0005, Cincinnati
University of Cincinnati Physicians Company, Cincinnati
Local Institution - 0188, Columbus
Local Institution - 0061, Mentor
Local Institution - 0060, Providence
Local Institution - 0177, Cordova
Local Institution - 0168, Nashville
Local Institution - 0036, Houston
Local Institution - 0163, Houston
Local Institution - 0161, Lubbock
GI Alliance: Mansfield - TDDC, Mansfield
Local Institution - 0039, Mansfield
Local Institution - 0201, San Antonio
Local Institution - 0043, San Antonio
San Antonio Gastroenterology, San Antonio
Local Institution - 0166, San Marcos
Local Institution - 0046, Tyler
Tyler Research Institute, LLC, Tyler
Local Institution - 0193, Ogden
Local Institution - 0169, Salt Lake City
Local Institution - 0130, Seattle
Local Institution - 0189, Tacoma
Local Institution - 0017, Madison
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY